Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

In vitro and in vivo studies show no lung deposition associated with Oralin

Nov. 13, 2001

New imidazoles for histamine H3-mediated disorders jointly identified by European labs

Nov. 12, 2001

Phase II results presented from AeroDose inhaled insulin study

Nov. 12, 2001

New series for obesity and sleep disorders disclosed by Actelion

Nov. 9, 2001

Recent patent covers BMS's new DPP-IV inhibitors

Nov. 9, 2001

Early NDA submission planned for Cellegy's testosterone gel

Nov. 9, 2001

Novel series useful for hormone-dependent diseases and in hormone replacement therapy

Nov. 8, 2001

Lead drug from Palatin exhibits preclinical efficacy in female sexual dysfunction

Nov. 8, 2001

Inhibitors of FBPase useful for diabetes and related conditions

Nov. 7, 2001

Phase III results for Aldurazyme support marketing approval application

Nov. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...